Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir for HIV Prevention in HSV-2+ Individuals
NCT00076232Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2005
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Acyclovir with Placebo (2 arms). Primary endpoint: Serologically confirmed HIV infection. Started Apr 2005; status: completed.
02
Drugs
aciclovir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00076232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076232.